Sign in
Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations
Journal article   Peer reviewed

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations

Hadrian Szpurka, Anna M. Jankowska, Hideki Makishima, Juraj Bodo, Nelli Bejanyan, Eric D. Hsi, Mikkael A. Sekeres and Jaroslaw P. Maciejewski
Leukemia research, Vol.34(8), pp.969-973
2010
PMCID: PMC2953471
PMID: 20334914

Abstract

ASXL1 JAK2 V617F MPL W515L RARS-T STAT5 TET2

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.103 Blood Disorders
1.103.155 Acute Myeloid Leukemia
Web Of Science research areas
Hematology
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details